)
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
Strong sales of the MG Cyberster and M9 Presidential Limousine push JSW MG Motor to the No.2 position in India's luxury EV space, with demand soaring across cities
Researchers design thin, low-cost gold electrodes that detect cardiac troponin I and uric acid in saliva, paving the way for portable, point-of-care diagnostics
Among major gainers, Aurobindo Pharma led the rally, surging 4.49 per cent to Rs 1,118.9, followed by Lupin, which climbed 2.73 per cent to Rs 1,957.6
The meeting between AHPI and insurers focused on a unified hospital empanelment system, quicker claim settlements, and improved patient experience nationwide
A global study says basic eye care like screenings and glasses can yield ₹16 for every ₹1 spent, boosting India's productivity and education outcomes
While such practices exist in leading private facilities, experts say public hospitals, often stretched and underfunded, struggle with outdated wiring, inadequate maintenance, and lax inspection
"The next decade will be defined by chips, and India will be at the centre of this transformation," Dhavse said
The move comes as the entry-level SUV market grows increasingly competitive, with players aggressively vying for market share
India's pharmaceutical market rose 7.3% year-on-year in September to ₹20,886 crore, driven by robust growth in antidiabetic, cardiac, and respiratory therapies
Once niche and costly, genomic testing is becoming affordable across India as prices fall 30-40 per cent, with hospitals and diagnostic chains expanding into Tier-2 and Tier-3 cities
Company executives added that the Adventure X trims are expected to lift sales volumes, though average selling prices may soften compared with last year, when demand was led by high-end variants
Tata Motors announced major leadership changes as it prepares to demerge its commercial vehicle business into TML Commercial Vehicles Ltd, effective October 1, 2025
Crisil projects India pharma growth at 7-9% in FY26 as exports to regulated markets slow after a US high base while domestic sales benefit from tax cuts and launches
Vector Consulting Group study finds pharma firms spend up to ₹75 cr annually on IT systems, but 70% of digital projects fail due to adoption gaps and poor execution
Apollo Hospitals to expand genomics institutes to Tier-2 cities including Guwahati, Bhubaneswar and Indore, aiming to cut test costs and boost access beyond metro regions
With new GST rates kicking in, auto dealers face uncertainty on recovering compensation cess from unsold stock, even as OEMs cut prices to spur festive demand
Hisar-based Zelio E-Mobility to raise Rs 78 crore through an SME IPO to fund new plants, strengthen R&D, reduce debt and enhance capacity to meet growing demand for EVs
India's millionaire households have nearly doubled to 8.7 lakh in four years, creating a runway for luxury car demand as wealth fuels aspirations and premium consumption
Lupin has received USFDA approval for generic Lenalidomide capsules in six strengths, adding to competition in the US oncology market for Bristol-Myers Squibb's Revlimid
Spinny has reduced used car prices ahead of GST reforms from September 22, offering buyers up to Rs 2 lakh savings and sellers up to Rs 20,000 higher resale benefit